Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
Clinical trial NCT02630693 · COMPLETED
Trial details
- NCT number
- NCT02630693
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-08
- Primary completion
- 2018-08-15
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.